Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Global Systematic Review of Primary Immunodeficiency Registries Publisher Pubmed



Abolhassani H1, 2 ; Azizi G3 ; Sharifi L1, 28 ; Yazdani R1 ; Mohsenzadegan M1 ; Delavari S1, 29 ; Sohani M1 ; Shirmast P1 ; Chavoshzadeh Z4 ; Mahdaviani SA5 ; Kalantari A6 ; Tavakol M3 ; Jabbariazad F7 ; Ahanchian H7 Show All Authors
Authors
  1. Abolhassani H1, 2
  2. Azizi G3
  3. Sharifi L1, 28
  4. Yazdani R1
  5. Mohsenzadegan M1
  6. Delavari S1, 29
  7. Sohani M1
  8. Shirmast P1
  9. Chavoshzadeh Z4
  10. Mahdaviani SA5
  11. Kalantari A6
  12. Tavakol M3
  13. Jabbariazad F7
  14. Ahanchian H7
  15. Momen T8
  16. Sherkat R9
  17. Sadeghishabestari M10
  18. Aleyasin S11
  19. Esmaeilzadeh H11
  20. Alherz W12, 13
  21. Bousfiha AA14, 15, 16
  22. Condinoneto A17, 18
  23. Seppanen M19, 20, 21
  24. Sullivan KE22, 23
  25. Hammarstrom L2
  26. Modell V24
  27. Modell F24
  28. Quinn J24
  29. Orange JS24, 25
  30. Aghamohammadi A1, 26, 27
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden
  3. 3. Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
  4. 4. Pediatric Infections Research Center, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases(NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Department of Immunology and Allergy, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. Department of Allergy and Clinical Immunology, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran
  9. 9. Acquired Immunodeficiency Research Center, Lsfahan University of Medical Sciences, Isfahan, Iran
  10. 10. Immunology research center of Tabriz, TB and lung research center of Tabriz, Children Hospital, Tabriz University of Medical Science, Tabriz, Iran
  11. 11. Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  12. 12. Department of Pediatrics, Kuwait University, Kuwait City, Kuwait
  13. 13. Allergy and Clinical Immunology Unit, Department of Pediatrics, Al-Sabah Hospital, Kuwait City, Kuwait
  14. 14. Laboratoire d’Immunologie Clinique, d’Inflammation Et d’Allergie LICIA, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco
  15. 15. Clinical Immunology Unit, Casablanca Children’s Hospital, Ibn Rochd Medical School, Hassan II University, Casablanca, Morocco
  16. 16. The African Society for Immunodeficiencies (ASID) Registry, United States
  17. 17. Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil
  18. 18. The Latin American Society for Immunodeficiencies (LASID) Registry, United States
  19. 19. Adult Immunodeficiency Unit, Infectious Diseases, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  20. 20. Rare Disease Center and Pediatric Research Center, Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  21. 21. European Society for Immunodeficiencies (ESID) Registry, United States
  22. 22. Division of Allergy Immunology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA, United States
  23. 23. The United States Immunodeficiency Network (USIDNET) Registry, United States
  24. 24. Jeffrey Modell Foundation (JMF), New York City, NY, United States
  25. 25. Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY, United States
  26. 26. Iranian Primary Immunodeficiencies Network (IPIN), Tehran University of Medical Science, Tehran, Iran
  27. 27. Asia Pacific Society for Immunodeficiencies (APSID) Registry, United States
  28. 28. Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  29. 29. Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences Iran University of Medical Sciences, Tehran, Iran

Source: Expert Review of Clinical Immunology Published:2020


Abstract

Introduction: During the last 4 decades, registration of patients with primary immunodeficiencies (PID) has played an essential role in different aspects of these diseases worldwide including epidemiological indexes, policymaking, quality controls of care/life, facilitation of genetic studies and clinical trials as well as improving our understanding about the natural history of the disease and the immune system function. However, due to the limitation of sustainable resources supporting these registries, inconsistency in diagnostic criteria and lack of molecular diagnosis as well as difficulties in the documentation and designing any universal platform, the global perspective of these diseases remains unclear. Areas covered: Published and unpublished studies from January 1981 to June 2020 were systematically reviewed on PubMed, Web of Science and Scopus. Additionally, the reference list of all studies was hand-searched for additional studies. This effort identified a total of 104614 registered patients and suggests identification of at least 10590 additional PID patients, mainly from countries located in Asia and Africa. Molecular defects in genes known to cause PID were identified and reported in 13852 (13.2% of all registered) patients. Expert opinion: Although these data suggest some progress in the identification and documentation of PID patients worldwide, achieving the basic requirement for the global PID burden estimation and registration of undiagnosed patients will require more reinforcement of the progress, involving both improved diagnostic facilities and neonatal screening. © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Other Related Docs
17. Noninfectious Complications in B-Lymphopenic Common Variable Immunodeficiency, Journal of Investigational Allergology and Clinical Immunology (2024)
23. Approach to the Management of Autoimmunity in Primary Immunodeficiency, Scandinavian Journal of Immunology (2017)
25. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, Journal of Investigational Allergology and Clinical Immunology (2017)
27. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment, Journal of Investigational Allergology and Clinical Immunology (2015)
28. Autoimmunity in Primary Antibody Deficiencies, International Archives of Allergy and Immunology (2017)
29. Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (Cvid), Endocrine, Metabolic and Immune Disorders - Drug Targets (2017)
30. Evaluation of Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, European Annals of Allergy and Clinical Immunology (2017)
33. Role of Rare Immune Cells in Common Variable Immunodeficiency, Pediatric Allergy and Immunology (2022)
34. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort, Journal of Allergy and Clinical Immunology: In Practice (2019)
35. Clinical Display, Diagnostics and Genetic Implication of Novel Coronavirus (Covid-19) Epidemic, European Review for Medical and Pharmacological Sciences (2020)
39. The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases, Endocrine, Metabolic and Immune Disorders - Drug Targets (2016)